KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Halozyme Therapeutics (HALO) Goodwill (2022 - 2025)

Historic Goodwill for Halozyme Therapeutics (HALO) over the last 4 years, with Q4 2025 value amounting to $580.4 million.

  • Halozyme Therapeutics' Goodwill rose 3923.48% to $580.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $580.4 million, marking a year-over-year increase of 3923.48%. This contributed to the annual value of $580.4 million for FY2025, which is 3923.48% up from last year.
  • As of Q4 2025, Halozyme Therapeutics' Goodwill stood at $580.4 million, which was up 3923.48% from $416.8 million recorded in Q3 2025.
  • In the past 5 years, Halozyme Therapeutics' Goodwill ranged from a high of $580.4 million in Q4 2025 and a low of $199.5 million during Q2 2022
  • Over the past 4 years, Halozyme Therapeutics' median Goodwill value was $416.8 million (recorded in 2023), while the average stood at $398.2 million.
  • Per our database at Business Quant, Halozyme Therapeutics' Goodwill surged by 10895.27% in 2023 and then changed by 0.0% in 2024.
  • Quarter analysis of 4 years shows Halozyme Therapeutics' Goodwill stood at $409.0 million in 2022, then rose by 1.9% to $416.8 million in 2023, then changed by 0.0% to $416.8 million in 2024, then surged by 39.23% to $580.4 million in 2025.
  • Its Goodwill was $580.4 million in Q4 2025, compared to $416.8 million in Q3 2025 and $416.8 million in Q2 2025.